TLRY - Tilray Brands, Inc.
7.06
-0.240 -3.399%
Share volume: 3,492,799
Last Updated: 03-05-2026
Pharmaceutical Products/Medicinal Chemicals:
2.23%
PREVIOUS CLOSE
CHG
CHG%
$7.30
-0.24
-0.03%
View ratios
| Fiscal Date | 02-28-2025 | 05-31-2025 | 08-31-2025 | 11-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Report Date | 04-08-2025 | 07-28-2025 | 10-09-2025 | 01-08-2026 | |
| Total revenue | 185.780 M | 224.535 M | 209.501 M | 217.507 M | |
| Cost of revenue | 133.769 M | 156.902 M | 152.032 M | 160.010 M | |
| Gross profit | 52.011 M | 67.633 M | 57.469 M | 57.497 M | |
| 30.04% | -15.03% | 0.05% | |||
| Operating expenses | 53.236 M | 52.284 M | 54.017 M | 63.034 M | |
| Selling general and admin | 53.151 M | 52.250 M | 53.976 M | 62.956 M | |
| Research and development | 85.000 K | 34.000 K | 41.000 K | 78.000 K | |
| Total expenses | 811.942 M | 1.512 B | 55.377 M | 79.776 M | |
| 86.17% | -96.34% | 44.06% | |||
| Operating income | -759.931 M | -1.444 B | 2.092 M | -22.279 M | |
| Ebit | -783.953 M | -1.389 B | 5.924 M | -34.589 M | |
| Pretax income | -792.331 M | -1.393 B | -772.000 K | -39.963 M | |
| 75.82% | -99.94% | 5,076.55% | |||
| Income tax | 1.203 M | -125.142 M | -2.285 M | 3.546 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -793.534 M | -1.268 B | 1.513 M | -43.509 M | |
| -59.78% | 100.12% | -2,975.68% |